ANGIOGENESIS
Scope & Guideline
Fostering Innovation in Vascular Biology Research
Introduction
Aims and Scopes
- Molecular Mechanisms of Angiogenesis:
Research that elucidates the molecular pathways and signaling cascades involved in angiogenesis, including factors like VEGF, angiopoietins, and various growth factors. - Endothelial Cell Biology:
Studies focusing on endothelial cell function, plasticity, and interactions in health and disease, particularly in the context of vascular development and pathology. - Pathological Angiogenesis:
Exploration of abnormal angiogenesis in diseases such as cancer, diabetic retinopathy, and hereditary hemorrhagic telangiectasia, highlighting potential therapeutic targets. - Vascular Development and Regeneration:
Research on the processes of vasculogenesis and angiogenesis during development and tissue repair, including the role of stem cells and tissue engineering. - Clinical Applications and Therapeutics:
Studies that translate basic research findings into clinical applications, focusing on novel therapies for conditions associated with aberrant angiogenesis. - Inflammation and Angiogenesis:
Investigations into how inflammatory processes influence angiogenic responses, particularly in the context of chronic diseases and infections.
Trending and Emerging
- Angiogenesis in COVID-19 and Post-Viral Syndromes:
Research addressing the role of angiogenesis in COVID-19 and its long-term effects, including complications like post-COVID syndrome and microvascular dysfunction. - Mitochondrial Dysfunction and Angiogenesis:
An increasing number of studies are exploring the interplay between mitochondrial function and angiogenesis, particularly in pathological conditions such as diabetic retinopathy. - Utilization of iPSC-Derived Endothelial Cells:
The use of induced pluripotent stem cells (iPSCs) to study endothelial cell behavior and disease mechanisms is gaining momentum, providing insights into vascular development and regeneration. - Role of Extracellular Vesicles in Angiogenesis:
Emerging research on the role of extracellular vesicles and small RNAs in modulating angiogenic processes, particularly in cancer and inflammatory diseases. - Mechanobiology of Endothelial Cells:
A growing interest in how mechanical forces and the physical properties of the vascular microenvironment influence endothelial cell behavior and angiogenesis. - Targeted Therapeutics in Cancer Angiogenesis:
A trend towards the development of targeted therapies that specifically inhibit angiogenesis in tumor microenvironments, reflecting the need for precision medicine in oncology.
Declining or Waning
- Traditional Angiogenesis Models:
There has been a noticeable decrease in studies relying solely on classical in vitro angiogenesis assays, as newer technologies and models like organ-on-a-chip systems gain traction. - Generalized Anti-Angiogenic Therapies:
Research focusing on broad-spectrum anti-angiogenic therapies has waned, with a shift towards more targeted and personalized approaches in specific diseases. - Static Analysis of Endothelial Cells:
The focus on static, non-dynamic analyses of endothelial cells has declined, giving way to more dynamic studies that incorporate mechanical forces and cellular interactions. - Non-Specific Biomarker Studies:
There has been a reduction in publications centered on generic biomarkers for angiogenesis, as more specific and mechanistic approaches are favored. - Angiogenesis in Non-Pathological Contexts:
Less emphasis is placed on studying angiogenesis in normal physiological contexts, with a stronger focus on pathological conditions and their therapeutic implications.
Similar Journals
CELL BIOCHEMISTRY AND FUNCTION
Decoding the Language of Cells for a Healthier TomorrowCELL BIOCHEMISTRY AND FUNCTION is a prominent journal dedicated to disseminating high-quality research in the fields of biochemistry, cell biology, and clinical biochemistry. Published by Wiley, this journal has maintained an esteemed reputation since its inception in 1983, bridging decades of scientific advancements and contributions until 2024. With ISSN 0263-6484 and E-ISSN 1099-0844, it serves as a vital resource for researchers, professionals, and students. The journal is classified in quartiles Q2 and Q3 across various categories in the 2023 rankings, showcasing its impact and significance within the academic community. Highlighting essential studies in medicinal biochemistry and cellular functionalities, CELL BIOCHEMISTRY AND FUNCTION not only presents cutting-edge research but also encourages interdisciplinary collaboration, thereby advancing the understanding of biochemical processes that underlie living systems. With no open access currently available, readers are encouraged to access articles through institutional subscriptions or individual purchases, ensuring exclusive engagement with the latest scientific findings in this dynamic field.
STEM CELLS AND DEVELOPMENT
Elevating Knowledge in Stem Cell Biology and DevelopmentSTEM CELLS AND DEVELOPMENT, published by Mary Ann Liebert, Inc., is a leading peer-reviewed journal dedicated to the rapidly advancing fields of stem cell biology and developmental science. With an ISSN of 1547-3287 and an E-ISSN of 1557-8534, the journal encompasses a broad range of topics central to understanding stem cells' roles in development and regeneration processes. It holds a prestigious standing within its category quartiles, ranking Q3 in Cell Biology, Q2 in Developmental Biology, and Q2 in Hematology for 2023. With its convergence from 2004 to 2024, STEM CELLS AND DEVELOPMENT fosters an innovative platform for researchers, professionals, and students to disseminate groundbreaking research, share insights, and explore novel therapeutic approaches. Open access options enhance the journal's visibility and accessibility, promoting a collaborative exchange of information among the scientific community. Positioned at the forefront of stem cell research and its applications, this journal is vital for anyone seeking to stay informed about the latest advancements and trends within these critical areas of study.
Journal of Biochemistry
Where groundbreaking biochemistry research comes to life.Journal of Biochemistry, published by Oxford University Press, is a prestigious academic journal that has been at the forefront of biochemical research since its inception in 1922. With an ISSN of 0021-924X and an E-ISSN of 1756-2651, this journal serves as a platform for disseminating high-quality research in the fields of biochemistry, molecular biology, and medicine, holding impressive rankings such as Q2 in Biochemistry and Medicine (miscellaneous) in 2023. As of 2024, the journal continues to explore significant topics in these areas, offering valuable insights for researchers, professionals, and students alike. The journal does not currently offer open access, but it remains a vital resource for anyone in the biochemical community seeking to stay updated on the latest discoveries and advancements. With its rich history and dedication to scientific excellence, the Journal of Biochemistry is an indispensable part of the scholarly landscape.
INTERNATIONAL ANGIOLOGY
Transforming Knowledge into Practice in AngiologyINTERNATIONAL ANGIOLOGY is a leading journal in the field of Cardiology and Cardiovascular Medicine, published by EDIZIONI MINERVA MEDICA. Since its inception in 1984, it has become an essential resource for researchers, clinicians, and students interested in the latest advancements and research in vascular health. With an ISSN of 0392-9590 and an E-ISSN of 1827-1839, the journal maintains a strong academic presence, reflected by its category quartile ranking of Q3 in 2023, positioning it among the noteworthy publications within the cardiology sector, as indicated by its Scopus rank of #209 out of 387. Although the journal is not open access, it provides a critical platform for disseminating knowledge on topics ranging from angiogenesis to interventional vascular procedures. As the journal continues to evolve towards its convergence in 2024, it remains committed to fostering academic discourse and delivering high-quality research that shapes the future of cardiovascular medicine.
VASCULAR PHARMACOLOGY
Connecting research and practice in vascular medicine.Vascular Pharmacology, published by Elsevier Science Inc, is a leading journal in the fields of pharmacology and molecular medicine, dedicated to advancing our understanding of vascular biology and therapeutic interventions. With an impressive impact factor reflecting its significant contribution to the scientific community, this journal seeks to publish ground-breaking research that elucidates the molecular mechanisms underlying vascular function and disease, as well as the pharmacological impact of new therapeutic agents. The journal operates under a dual access model, allowing for both subscription and open access options, ensuring that vital research is accessible to a wide audience. As of 2023, it holds a prestigious position in the Q1 category for pharmacology and ranks well in molecular medicine and physiology, reflecting its high quality and relevance. Whether you are a researcher, clinician, or student, Vascular Pharmacology serves as an essential resource to stay at the forefront of cardiovascular pharmacotherapy and vascular biology.
Journal of Developmental Biology
Fostering Innovation in Biological DevelopmentJournal of Developmental Biology, published by MDPI, is an esteemed open access journal that has been contributing to the field since its inception in 2013. With a focus on developmental processes across various biological systems, this journal serves as a vital platform for disseminating cutting-edge research and fostering dialogue among experts in the fields of Cell Biology, Developmental Biology, and Molecular Biology. The journal currently holds a commendable Q2 ranking in both Developmental Biology and Molecular Biology, underscoring its significance in advancing knowledge within these domains. Operating out of Switzerland, and featuring an engaging array of articles, the journal prioritizes accessibility through its Open Access model, further expanding the reach of vital research findings. Whether you are a seasoned researcher or an enthusiastic student, the Journal of Developmental Biology provides an essential resource for the latest insights and developments in this rapidly evolving field.
JOURNAL OF MOLECULAR HISTOLOGY
Pioneering the intersection of science and medicine.The Journal of Molecular Histology, published by Springer, stands at the forefront of multidisciplinary research in cellular and molecular histology, offering vital contributions in the fields of Cell Biology, Histology, and Medicine. With an ISSN of 1567-2379 and an E-ISSN of 1567-2387, this peer-reviewed journal has maintained its commitment to advancing knowledge since its inception in 2004 and continues to thrive into 2024. The journal, located in The Netherlands, boasts a robust impact within its categories, currently holding Q3 rankings in Cell Biology and Q2 rankings in Histology, Medicine, and Physiology, highlighting its relevance to academics and professionals alike. With Scopus rankings that reflect a strong percentile presence across multiple fields, the journal emphasizes open access options to enhance the dissemination of critical research findings. As a valuable resource for researchers, professionals, and students engaged in molecular exploration, the Journal of Molecular Histology fosters innovation and collaboration, making significant impacts on our understanding of tissue structure and function.
JOURNAL OF VASCULAR RESEARCH
Unveiling the complexities of vascular dynamics.Welcome to the JOURNAL OF VASCULAR RESEARCH, a reputable academic journal published by KARGER that has been a cornerstone of vascular research since 1964. With an ISSN of 1018-1172 and an E-ISSN of 1423-0135, this journal plays a vital role in disseminating cutting-edge research in the fields of Cardiology and Cardiovascular Medicine and Physiology. Currently categorized in the Q3 quartile for both disciplines, it ranks as #179 in Cardiology and #131 in Physiology according to Scopus, showcasing its significant contribution to the scientific community. Although the journal operates on a subscription basis, it strives to provide accessible content that informs and inspires researchers, professionals, and students alike. As the journal looks forward to its convergence in 2024, it continues to uphold its mission of advancing knowledge, fostering innovation, and encouraging collaboration within the dynamic realm of vascular research.
GROWTH FACTORS
Connecting researchers to the forefront of scientific discovery.GROWTH FACTORS, published by Taylor & Francis Ltd, is a prestigious journal dedicated to advancing the field of cell biology, clinical biochemistry, and endocrinology. With an ISSN of 0897-7194 and an E-ISSN of 1029-2292, this journal has served as a vital platform for the dissemination of groundbreaking research since its inception in 1988. Although it operates without an Open Access model, GROWTH FACTORS focuses on providing high-quality, peer-reviewed articles that explore the intricate roles of growth factors in biological processes and their implications in health and disease. Holding a Q4 ranking in Cell Biology and Q3 rankings in Clinical Biochemistry and Endocrinology according to the 2023 category quartiles, the journal is well-regarded in its field and plays a crucial role in informing researchers, professionals, and students alike about the latest findings and innovations in these areas. The journal's commitment to fostering scientific dialogue ensures that it remains a key resource for those looking to enhance their understanding of growth factors and their applications in clinical settings.
Frontiers in Cell and Developmental Biology
Exploring the intricate dance of development and biology.Frontiers in Cell and Developmental Biology is a leading open-access journal published by FRONTIERS MEDIA SA, dedicated to advancing the understanding of fundamental biological processes at the cellular and developmental levels. Since its inception in 2013, the journal has positioned itself as a cornerstone of research in its field, achieving esteemed Q1 quartile rankings in both Cell Biology and Developmental Biology for 2023. With a robust Scopus ranking of #13 out of 82 in Developmental Biology and #67 out of 285 in Cell Biology, it represents a vital platform for innovative research and scholarly discourse. The journal provides a comprehensive and accessible avenue for researchers, professionals, and students alike to share high-quality findings and insights into cellular mechanisms and developmental processes, fostering collaboration and knowledge exchange in the global scientific community. Based in Lausanne, Switzerland, Frontiers in Cell and Developmental Biology is committed to open science, ensuring that all articles are freely accessible to the public, thereby broadening the impact of research in the biological sciences.